Osgood aways sounds that way. It could be dramatic style, or it could be that he reads no copy without being paid to run the spot.
Cologuard currently only tests for CRC. The platform is certainly capable of being expanded to test for those things you mention, by adding the capability to detect DNA markers unique to those organisms. While screens for other issues are possible, the company works on a "one at a time" basis. Once Cologuard has fully launched, they are likely to start in earnest on pancreatic cancer. The other GI cancers are likely to occupy their time for the foreseeable future. If it were to become an "all in one" GI and lung cancer screen, it would have already become more ubiquitous than blood lipids.
You mention using standard tests for parasites and bacterial infections. If you are referring to using the same stool sample to run the currently available tests, the only value added there would be in the stool collection - simply not worth the effort. Standard tests for parasites involves microscopic examination for eggs, which does to lend itself to widespread screening.
Can anyone with a Medicare Summary Notice for a recent screening colonoscopy post the amount covered? A few responses will not give us the national average, but it will give us a hint.
BTW, the $20,000 toilet seats and $5,000 hammers were part of the accounting magic used to fund the development weapon systems that would otherwise raise eyebrows if part of the budget. Everyone does not get to know about every military project.
1 million tests / 250 work days per year is 4,000 tests per day. The carriers can certainly handle the volume. The real problem is with Exact's staff handling the test volume. Assuming it takes 5 minutes just to open each package, record the patient data in the system (probably just scanning a bar code, meaning most of the data entry was done during patient registration) and put the sample container into the processing queue, then you would need 41 people working an 8 hour day. Assuming there is not a machine to open the sample containers (why not?) and process everything up to the point of PCR, then the receiving processing is the easy part.
Please do. I think it is just a web master issue, since other parts of the same web site talk about the newly approved sDNA test. Even the link for sDNA under the heading of "Unapproved Tests" takes you to a page that says it is approved.
To see if they are enrolled with Exact Sciences?
If your doctor is enrolled, have you requested the test?
Have you asked friends to do the same?
Screening is important, and we (longs) are all in sales now.
From the SEC web site:
"On October 29, 2010, RA Capital sold short 75,000 shares of Exact Sciences Corp. (“EXAS”) during the restricted period at a price of $7.35 per share. On November 4, 2010, EXAS announced the pricing of a follow-on offering of its common stock at $6.00 per share. RA Capital received an allocation of 600,000 shares in that offering. The difference between RA Capital’s proceeds received from the restricted period short sales of EXAS shares and the price for the 600,000 shares received in the offering was $101,385.00. Respondent also improperly obtained a benefit of $141,382.50 by purchasing the remaining 525,000 shares at a discount from EXAS’s market price. Thus, RA Capital’s participation in the EXAS offering netted total profits of $242,767.50."
The idea of finding the point on the price versus demand curve that provides the maximum profit really only applies to a free market. Once insurance is entered into the equation, people no longer think of it as spending their own money, so the price becomes a secondary factor. A high price may make some carriers balk and refuse to cover it until USPSTF guidelines force the issue. If that's the case, then it will behave as a free market. The highest price that gets all the carriers on board will be the one that works.
I'm happy with $300. I think at $300, even those whose insurance does not (yet) cover Cologuard will be likely to buy it outright. $300 leaves room to grow proportionally with additional screens.
"As far as the seen this play out comment I was referring to what I feel lies ahead for this company..."
I am aware of the context of your statement, but if you've seen that all play out before, then you must also have noticed the tendency of events to be delayed and, coincidentally, frequently delayed until after the nearest options expiration, usually accompanied by a decline in the price of the underlying security. The other completely predictable nature of options is the disappearance of the time premium.
"...I've seen this play out so many times before..."
Then why did you hold event-dependent options into their final week?
The crash of `08 changed the risk tolerance for many investors - they're just not willing to hold a speculative play through a general market dip, for fear that negative company impacts that occur during the lull will prevent the share price from recovering with the market.
Is there any way to save Time & Sales data to a file? With Fidelity, you can see Time & Sales data for stock and options on a scrollable window, but you can only manually save up to 3 screen buffers at a time. Pretty clunky.
Please forward that, and other such conflict of interest information, to Exact's Investor Relations department.